Clinical Study of Hydroxytyrosol (HT) in Mitochondrial Diseases

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 5, 2022

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Mitochondrial Diseases
Interventions
DIETARY_SUPPLEMENT

hydroxytyrosol (HT) intake

MD patients will receive hydroxytyrosol (HT) daily as dietary supplements for 12 months. After that, patients will be randomly assigned in 1:1 ratio to continue on receiving hydroxytyrosol (HT) as their dietary supplements for another 6 months.

DIETARY_SUPPLEMENT

hydroxytyrosol (HT) intake and withdraw

MD patients will receive hydroxytyrosol (HT) daily as dietary supplements for 12 months. After that, patients will be randomly assigned in 1:1 ratio to withdraw from receiving hydroxytyrosol (HT) as their dietary supplements for another 6 months.

Trial Locations (1)

Unknown

Hong Kong Children's Hospital, Hong Kong

All Listed Sponsors
collaborator

The University of Hong Kong

OTHER

lead

Hong Kong Children's Hospital

OTHER